ARCHIVES

FDA Proposes New User Fees for Generics and Biosimilar Products

This article is from The Cancer Letter archive.

Vol. 38 No. 03 | January 20, 2012

Download PDF Visit The Full Archive

Related Articles

Foundations Invites Antitobacco Proposals

October 15, 1993

Also Senate, House committees request further research, reports from NCI.

September 19, 2003

ACS names new officers.

December 5, 2003

ODAC Recommends TICE BCG Approval For Recurrent Bladder Cancer Prevention

January 10, 1997

NCI Advisory Group, Other Cancer Meetings

January 2, 1981

Duke Comprehensive Cancer Center Wins Core Grant Renewal

September 17, 2010